Research and Markets: Kidney Transplantation Therapeutics Pipeline Report 2015 - 25 Companies & 30 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5kh54v/kidney) has announced the addition of the "Kidney Transplantation - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Kidney transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney transplantation and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Alexion Pharmaceuticals, Inc.
  • Amyndas Pharmaceuticals LLC
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • Bio-inRen
  • Catalyst Biosciences, Inc.
  • CSL Limited
  • Digna Biotech, S.L.
  • Dompe Farmaceutici S.p.A.
  • Effimune SAS
  • GlaxoSmithKline Plc
  • Grifols, S.A.
  • Hansa Medical AB
  • Kyowa Hakko Kirin Co., Ltd.
  • Mabtech Limited
  • Novartis AG
  • Onyx Pharmaceuticals, Inc.
  • Opsona Therapeutics Limited
  • Pharming Group N.V.
  • Prolong Pharmaceuticals
  • Quark Pharmaceuticals, Inc.
  • Shire Plc
  • t-cell Europe GmbH
  • Tiziana Life Sciences Plc
  • Zyrnat Biotherapeutics SL

Drug Profiles

  • albumin (human)
  • AMY-101
  • AS-2521780
  • basiliximab biobetter
  • BB-3
  • belimumab
  • bleselumab
  • BRN-1889
  • C1 esterase inhibitor (human)
  • Cardiotrophin-1
  • carfilzomib
  • CB-2782
  • Cell Therapy for Kidney Transplantation
  • CFZ-533
  • Dendritic Cell Therapy for Multiple Sclerosis and Kidney Transplantation
  • eculizumab
  • EFFI-7H
  • ETR-002
  • FCR-001
  • foralumab
  • FR-104
  • FX-06
  • Monoclonal Antibody to Inhibit CD47 for Kidney Transplantation, Cardiovascular Disease and Oncology
  • OPN-305
  • QPI-1002
  • Recombinant Enzyme to Inhibit Immunoglobulin G for Kidney Transplantation
  • reparixin
  • Sanguinate
  • T-Cell Therapy for Kidney Transplant
  • ZY-11

For more information visit http://www.researchandmarkets.com/research/5kh54v/kidney

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders